PulmOne USA Inc. has entered into a partnership agreement with Circassia Pharmaceuticals to offer the NIOX VERO fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an integrated add-on to PulmOne’s MiniBox+.
Read more here.
![[Alpha Tau in Medium] Washington is one of first states to license promising new cancer treatment](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
